EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Male gonadal function and cancer treatment: Current perspectives

Koji Chiba iD, Hideaki Miyake

Investigative and Clinical Urology · 2026 · 67 (6) · 506

DOI: 10.4111/icu.20260397 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Investigative and Clinical Urology, 2026. Verfasst von Koji Chiba und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan. kchiba@med.kobe-u.ac.jp. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsHumansMaleFertility PreservationSpermatogenesisLeydig CellsCryopreservationAzoospermia

Stichwörter der Autor:innen

Cancer survivorshipCryopreservationFertility preservationGonadal disordersLeydig cells

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan. kchiba@med.kobe-u.ac.jp.
  • Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.

ORCID-Profile: Koji Chiba

Zitieren

APA

Chiba, K., & Miyake, H. (2026). Male gonadal function and cancer treatment: Current perspectives. Investigative and Clinical Urology, 67(6), 506. https://doi.org/10.4111/icu.20260397

Vancouver

Chiba K, Miyake H. Male gonadal function and cancer treatment: Current perspectives. Investigative and Clinical Urology. 2026;67(6):506. doi:10.4111/icu.20260397

BibTeX
@article{Chiba2026,
  author = {Chiba, Koji and Miyake, Hideaki},
  title = {Male gonadal function and cancer treatment: Current perspectives},
  journal = {Investigative and Clinical Urology},
  year = {2026},
  volume = {67},
  number = {6},
  pages = {506},
  doi = {10.4111/icu.20260397}
}
Kostenlos starten →